Vistagen Therapeutics VTGN
NASDAQ VTGN
$0.20 +0.00 (+0.76%)
As of: Oct 21, 2026 · 11:25 AM EDT

Vistagen Therapeutics (VTGN) Other financing activities (2020 - 2022)

Updated

Vistagen Therapeutics' Other financing activities was $29,400 in fiscal Q1 2021 (quarter ended Jun 30, 2020).

Analysis

Vistagen Therapeutics (VTGN) Other financing activities (2020 - 2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,131.24 Bn 1,099.82 Bn 19.71 Bn
2 Johnson & Johnson 614.68 Bn 533.21 Bn 17.26 Bn
3 AbbVie 503.28 Bn 476.39 Bn 12.70 Bn
4 Merck 368.01 Bn 322.38 Bn 12.21 Bn
5 Novartis Ag 298.43 Bn 262.42 Bn 11.24 Bn
6 Astrazeneca 261.67 Bn 235.36 Bn 12.86 Bn
7 Amgen 236.03 Bn 191.43 Bn 7.24 Bn
8 Gilead Sciences 190.92 Bn 165.12 Bn 6.22 Bn
9 Pfizer 169.80 Bn 116.45 Bn 10.94 Bn
10 Vistagen Therapeutics 8.55 Mn -207.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 -59,400.00
Jun 30, 2021 -161,900.00
Jun 30, 2020 -29,400.00
API Access

Vistagen Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=VTGN&period=max&api_key=YOUR_API_KEY